Molecular and immune biomarker testing in squamous-cell lung cancer: effect of current and future therapies and technologies.
Name:
PIIS1525730418300561.pdf
Size:
393.5Kb
Format:
PDF
Description:
Full text, Open Access article
Authors
Hirsch, FKerr, K
Bunn, P
Kim, E
Obasaju, C
Pérol, M
Bonomi, P
Bradley, J
Gandara, D
Jett, J
Langer, C
Natale, R
Novello, S
Paz-Ares, L
Ramalingam, S
Reck, M
Reynolds, C
Smit, E
Socinski, M
Spigel, D
Stinchcombe, T
Vansteenkiste, J
Wakelee, H
Thatcher, Nick
Affiliation
Division of Medical Oncology, University of Colorado Cancer Center, Aurora, CO.Issue Date
2018-07
Metadata
Show full item recordAbstract
Patients with non-small-cell lung cancer, including squamous-cell lung cancer (SqCLC), typically present at an advanced stage. The current treatment landscape, which includes chemotherapy, radiotherapy, surgery, immunotherapy, and targeted agents, is rapidly evolving, including for patients with SqCLC. Prompt molecular and immune biomarker testing can serve to guide optimal treatment choices, and immune biomarker testing is becoming more important for this patient population. In this review we provide an overview of current and emerging practices and technologies for molecular and immune biomarker testing in advanced non-small-cell lung cancer, with a focus on SqCLC.Citation
Molecular and immune biomarker testing in squamous-cell lung cancer: effect of current and future therapies and technologies. 2018, 19(4): 331-339 Clin Lung CancerJournal
Clinical Lung CancerDOI
10.1016/j.cllc.2018.03.014PubMed ID
29773328Type
ArticleLanguage
enISSN
1938-0690ae974a485f413a2113503eed53cd6c53
10.1016/j.cllc.2018.03.014
Scopus Count
Collections
Related articles
- Emerging drugs for squamous cell lung cancer.
- Authors: Cheng H, Shcherba M, Kandavelou K, Liang Y, Liu H, Perez-Soler R
- Issue date: 2015 Mar
- [Progress on the Study of Targeting FGFR in Squamous Non-small Cell Lung Cancer].
- Authors: Dong M, Li T, Chen J
- Issue date: 2018 Feb 20
- [PD-L1 expression: An emerging biomarker in non-small cell lung cancer].
- Authors: Adam J, Planchard D, Marabelle A, Soria JC, Scoazec JY, Lantuéjoul S
- Issue date: 2016 Jan
- [Research status on molecular targeted therapy for squamous-cell lung cancer].
- Authors: Li Y, Zhou Y, Wang H
- Issue date: 2014 Aug 20
- Best practice in the treatment of advanced squamous cell lung cancer.
- Authors: Ang YL, Tan HL, Soo RA
- Issue date: 2015 Oct